Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Acadia Healthcare Company, Inc. on May 6, 2026. The Company is a holding company operating acute inpatient psychiatric facilities, specialty treatment centers, and outpatient behavioral healthcare services across the U.S. and Puerto Rico.
Financial Metrics
This filing is a corporate governance report regarding stockholder voting results. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent 10-K or 10-Q filings for financial performance details.
Material Changes and Voting Results
The filing details the outcomes of four proposals voted on by stockholders:
- Proposal 1 (Election of Class III Directors):
- Daniel J. Cancelmi: Elected (80,276,613 For; 608,441 Against).
- Michael J. Fucci: Elected (73,587,992 For; 7,296,976 Against).
- Patrice A. Harris, M.D., M.A.: Elected (80,535,426 For; 350,255 Against).
- Proposal 2 (Incentive Compensation Plan Amendment): Stockholders approved the second amendment to the Amended and Restated Incentive Compensation Plan (80,102,444 For; 779,641 Against).
- Proposal 3 (Say-on-Pay): Stockholders approved, on a non-binding advisory basis, the compensation of Named Executive Officers (60,889,503 For; 19,942,924 Against).
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 (83,941,435 For; 1,947,371 Against).
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the submission of matters to a vote of security holders.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class III directors, who will serve until the 2029 annual meeting.
- Review the specific terms of the "Second Amendment to the Incentive Compensation Plan" (Exhibit 10.2) to understand changes to executive equity incentives.
- Note the significant "Against" vote count (approx. 20 million shares) on the Say-on-Pay proposal, which may indicate shareholder sentiment regarding executive compensation.
- Confirm the appointment of Ernst & Young LLP as the auditor for the 2026 fiscal year.